Marvell Tech (MRVL): Hyperscaler Deal Timing Fuels Investor Scrutiny

Marvell Technology (NASDAQ: MRVL) faces investor scrutiny over the timing of its substantial hyperscaler agreement, a deal analysts estimate could yield up to $120 billion in revenue over approximately six and a half years. While the agreement signifies substantial future growth, a significant portion of its financial impact is projected to materialize from fiscal year 2029 and beyond, leading to concerns regarding near-term revenue drivers.

The company's prior outlook had projected custom revenue to more than double in fiscal 2028. Management now indicates that the custom numbers for fiscal 2029 and subsequent years will be considerably higher. The company's fiscal Q3 2027 non-GAAP gross margin guidance dips slightly to a range of 57.5%–58.5%, attributed by management to product mix, particularly the ramp-up of custom chips.

Separately, Marvell's raised fiscal 2028 revenue outlook stands at approximately $18 billion, an increase of $1.5 billion from previous projections, with connectivity products like optical interconnects and switching products cited as key drivers. The company anticipates its non-GAAP operating margin will enter its 38% to 40% target range in fiscal Q4 2027, reaching the higher end in fiscal 2028.

Investors are weighing the long-term potential against the immediate revenue streams. Marvell's Investor Day on October 6 is anticipated to provide further clarity on revenue projections through the end of the decade. The stock experienced an 8% drop in premarket trading on August 28, reflecting apprehension over the timeline for the hyperscaler deal's revenue realization.